Cell and gene therapies have been quickly gaining traction with many market approvals anticipated yearly. Speed is of the essence, which is why having a partner who knows what’s expected in regulated environments, has the flexibility to serve your unique needs, and can assist across your entire value chain is so important. Thermo Fisher Scientific’s Patheon business has the expertise and flexibility you need to continue moving at a rapid pace.
Thermo Fisher Scientific’s Patheon business has been active in pharmaceutical manufacturing for over 20 years. We know what regulatory authorities are looking for and how to design facilities compatible with commercial therapeutics so you can breeze through Pre-Approval Inspections and start manufacturing quickly.
Our expertise across various therapeutic strategies (eg: different cell types, genetic modification technologies, autologous, allogeneic, etc) combined with our ability to build a facility according to your specifications means we have the flexibility to support your unique process. A “just-in-time” strategy for facility buildout means we can complete your space in less than 9 months from time of order to facility qualification. Let’s build your solution together.
Not only do we offer process and analytical development, GMP space and manufacturing expertise, but we can also serve you with customizable apheresis collection kits and associated clinical/manufacturing site storage and logistics. That means our service offering spans from the start of patient material collection all the way to the finish line of delivering finished clinical material to patient treatment sites.
Cell and gene therapy has the potential to greatly advance the field of healthcare and patient outcomes. That’s why we are investing in strategic partnerships that combine Thermo Fisher Scientific’s product and CDMO expertise with partner insights to develop processes and products to advance the cell therapy workflow and expedite successful patient outcomes.